Table 1.

Distribution of study subject characteristics by disease grade

	CIN1		CIN2		CIN3		Cancer
	(N=27)		(N=8)		(N=10)		(N=23)
Age (range)*	37.5	(24–56)	35	(21–52)	37	(29–50)	54.3	(24–75)
Race
African-American	11	41%	6	75%	4	40.0%	12	52%
Caucasian	10	37%	2	25%	6	60.0%	9	39%
Asian/Other	0	0%	0	0%	0	0.0%	1	4%
Unknown	6	22%	0	0%	0	0.0%	1	4%
Ethnicity
Hispanic	15	56%	5	62.5%	6	60.0%	5	22%
Non-Hispanic	12	44%	3	37.5%	4	40.0%	18	78%
HIV serostatus
HIV negative	20	74%	3	37.5%	9	90.0%	22	96%
HIV positive	7	26%	5	62.5%	1	10.0%	1	4%
HPV DNA status
HPV negative	5	19%	1	12.5%	2	20.0%	0	0%
HPV DNA positive	22	81%	7	87.5%	8	80.0%	23	100%
High-risk HPV positive†	15	56%	5	62.5%	8	80.0%	23	100%

^*Mean age (range).

^†High-risk HPV included types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58 & 59.